Navidea Biopharmaceuticals, inc. (NAVB)

HEALTH CARE: HEALTH CARE SUPPLIES
SIC: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES

4995 BRADENTON AVENUE DUBLIN, OH 43017

Navidea Biopharm manufactures a line of gamma radiation detection equipment used in the application of intraoperative lymphatic mapping. The company is also developing and commercializing a line of blood flow monitoring devices for a variety of diagnostic and surgical applications.

Data based on most recent fiscal year report
Market Cap56.791 Million Shares Outstanding162.26 Million Avg Volume726.477 Thousand
1-Yr BETA vs S&P TR1.302 Current Ratio1.71 Quick Ratio1.71
View SEC Filings from NAVB instead.
Q1 2019 All Institutions Hedge Funds 1
To trade NAVB now:
Filers who had this stock in their top 10: 0 0 (0.0%)
13F Filers holding this stock: 48 5 (0.51%)
Aggregate 13F shares on 03/31/2019: 519.805 Thousand 22.963 Thousand
Aggregate 13F shares on 12/31/2018: 493.779 Thousand 10.292 Thousand
Percent change: 5.27% 123.12%
Funds creating new positions: 4 1
Funds Adding to an existing position: 10 1
Funds closing out their position: 12 1
Funds reducing their position: 4
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding NAVB (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

367.6 Thousand total shares from 7 transactions

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

LATKIN JED CEO, COO & CFO

  • Officer
  • Director
11,950 2019-05-16 3

BRUCK CLAUDINE

  • Director
7,550 2019-05-13 2

DRAKE PETER F

  • 10% Owner
62,540 2019-05-09 0

KARSEN PERRY A

  • Director
0 2019-04-23 0

SCOTT JOHN K JR.

  • 10% Owner
22,464,350 2019-03-22 2

CUTLER ADAM D. SEE REMARKS

  • Officer
0 2019-02-15 3

RICE YEHUDA MICHAEL

  • Director
150,000 2019-02-07 1

ROUAN SARAH KATHRYN

  • Director
100,000 2019-02-07 3

ROSOL MICHAEL STANLEY CHIEF MEDICAL OFFICER

  • Officer
0 2019-01-02 2

ROWINSKY ERIC K

  • Director
550,000 2019-01-01 0

COPE FREDERICK O SVP & CSO

  • Officer
585,052 2018-06-29 1

GUETH ANTON

  • Director
0 2018-06-08 0

FIORINO ANTHONY S. CHIEF MEDICAL OFFICER AND COO

  • Officer
75,000 2018-05-22 0

GREENE MARK I

  • Director
157,244 2018-02-20 0

REGAN WILLIAM J. SVP & CCO

  • Officer
172,977 2017-06-29 0

GOLDBERG MICHAEL M PRESIDENT & CEO

5,921,023 2017-05-16 0

KLIMA THOMAS J SVP & CHIEF COMMERCIAL OFFICER

  • Officer
51,935 2017-02-06 0

TROUP GORDON A

  • Director
No longer subject to file 2016-04-20 0

LARSON BRENT L EVP, CFO, TREAS & SEC'Y

  • Officer
0 2016-02-25 0

FORD BRENDAN A

  • Director
239,950 2015-07-31 0

TOMBLYN MICHAEL SVP, CHIEF MED. OFFICER

  • Officer
100,000 2015-07-02 0

TULIP THOMAS H. CHIEF BUS. OFFICER

  • Officer
77,966 2015-03-26 0

NORDLICHT MARK

PLATINUM MANAGEMENT (NY) LLC

LANDESMAN URI

PLATINUM LIQUID OPPORTUNITY MANAGEMENT (NY) LLC

PLATINUM PARTNERS LIQUID OPPORTUNITY MASTER FUND L.P.

PLATINUM PARTNERS VALUE ARBITRAGE FUND, LP

PLATINUM-MONTAUR LIFE SCIENCES, LLC

  • 10% Owner
2,285,346 2014-12-18 0

GONZALEZ RICARDO J CHIEF EXECUTIVE OFFICER

  • Officer
0 2014-10-13 0

NORDLICHT MARK

PLATINUM MANAGEMENT (NY) LLC

PLATINUM PARTNERS VALUE ARBITRAGE FUND, LP

LANDESMAN URI

PLATINUM LIQUID OPPORTUNITY MANAGEMENT (NY) LLC

PLATINUM PARTNERS LIQUID OPPORTUNITY MASTER FUND L.P.

  • 10% Owner
15,106,431 2014-08-12 0

PYKETT MARK JEROME

  • Director
318,505 2014-06-01 0

REININGER CORNELIA SVP & CHIEF MEDICAL OFFICER

  • Officer
0 2014-01-28 0

PLATINUM-MONTAUR LIFE SCIENCES, LLC

PLATINUM PARTNERS VALUE ARBITRAGE FUND, LP

  • 10% Owner
  • SEE EXPLANATION OF RESPONSES
10,073,375 2013-11-13 0

BROWN RODGER A VICE PRESIDENT

  • Officer
123,027 2013-03-13 0

JONES JESS

  • Director
29,250 2013-02-21 0

ASCHINGER CARL J JR

  • Director
0 2012-01-30 0

BUPP DAVID C

  • Director
2,843,130 2011-11-17 0

BLAIR ANTHONY K VP-MANUFACTURING & OPERATIONS

  • Officer
38,544 2011-05-27 0

RASH DOUGLAS L VICE PRESIDENT, MARKETING

  • Officer
0 2010-12-21 0

JOHNSON OWEN E

  • Director
70,000 2010-12-08 0

MILLER FRED B

  • Director
141,000 2010-06-16 0

AVITAL REUVEN

  • Director
289,256 2010-03-16 0

WHITLEY J FRANK

  • Director
61,500 2009-12-30 0

BLAND KIRBY I

  • Director
0 2009-01-05 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

LATKIN JED - Director - Officer CEO, COO & CFO

2019-05-17 P 1,000 $1.46 a 11,950 11,950.00 direct

LATKIN JED - Director - Officer CEO, COO & CFO

2019-05-16 P 1,500 $1.45 a 10,950 11,950.00 direct

LATKIN JED - Director - Officer CEO, COO & CFO

2019-05-15 P 1,000 $1.45 a 9,450 9,450.00 direct

LATKIN JED - Director - Officer CEO, COO & CFO

2019-05-14 P 2,000 $1.84 a 8,450 9,450.00 direct

BRUCK CLAUDINE - Director

2019-05-13 P 2,550 $1.90 a 7,550 7,550.00 direct

LATKIN JED - Director - Officer CEO, COO & CFO

2019-05-13 P 2,400 $1.91 a 6,450 9,450.00 direct

SCOTT JOHN K JR. - > 10% Owner

2019-03-22 P 357,143 $0.14 a 22,261,565 22,464,350.00 direct
Click here to report any possible errors with this stock listing.

Elevate your investments